Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth
Go back to Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth| VERACYTE (NASDAQ: VCYT) | Delayed: 58.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.55 | 52 Week High | $8.45 | |||
| Open | $58.55 | 52 Week Low | $4.21 | |||
| Day High | $58.55 | P/E | N/A | |||
| Day Low | $58.55 | EPS | $-1.52 | |||
| Volume | 21 | |||||

